Release of interleukins during tolerance and rejection of human renal allografts.
Charpentier
B
B
Laboratoire de Transplantation d'Organes, Faculté de Médecine Paris-Sud, Hôpital Paul Brousse, Villejuif, France.
Lantz
O
O
Lang
P
P
Martin
B
B
Fries
D
D
D003524:Cyclosporins / Q000627:therapeutic use; D003601:Cytotoxicity Tests, Immunologic; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D006801:Humans; D007375:Interleukin-1 / Q000096:biosynthesis*; D007376:Interleukin-2 / Q000096:biosynthesis*; D007377:Interleukin-3 / Q000096:biosynthesis*; D016030:Kidney Transplantation / Q000276:immunology*; D017710:Lymphocyte Transfusion; D014184:Transplantation, Homologous
D003524:Cyclosporins; D007375:Interleukin-1; D007376:Interleukin-2; D007377:Interleukin-3